Filing
Spy
Filing
Spy
Home
About
MRK
Merck & Co., Inc.
Global research-intensive biopharmaceutical company
CUSIP: 589331107
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2014 Q2
31 of 35 quarters
Total Value
$64.80B
Total Shares
1.12M
Net Share Change
-8.3K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Kahn Brothers Group
$64.80B
1.12M
9.4%
TRIM
-8.3K
(-0.7%)
Kahn Brothers Group
$64.80B
1.12M shares
TRIM
-8.3K
(-0.7%)
MRK — Merck & Co., Inc. - FilingSpy